|
1
|
Pitti RM, Marsters SA, Lawrence DA, Roy M,
Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT,
et al: Genomic amplification of a decoy receptor for Fas ligand in
lung and colon cancer. Nature. 396:699–703. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and
Kwon BS: A newly identified member of tumor necrosis factor
receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J
Biol Chem. 274:13733–13736. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Migone TS, Zhang J, Luo X, Zhuang L, Chen
C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, et al: TL1A is a
TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell
costimulator. Immunity. 16:479–492. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gill RM and Hunt JS: Soluble receptor
(DcR3) and cellular inhibitor of apoptosis-2 (cIAP-2) protect human
cytotrophoblast cells against LIGHT-mediated apoptosis. Am J
Pathol. 165:309–317. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin WW and Hsieh SL: Decoy receptor 3: A
pleiotropic immunomodulator and biomarker for inflammatory
diseases, autoimmune diseases and cancer. Biochem Pharmacol.
81:838–847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wan X, Shi G, Semenuk M, Zhang J and Wu J:
DcR3/TR6 modulates immune cell interactions. J Cell Biochem.
89:603–612. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Siakavellas SI, Sfikakis PP and Bamias G:
The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases. Semin
Arthritis Rheum. 45:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu Y, Han B, Sheng H, Lin M, Moore PA,
Zhang J and Wu J: Clinical significance of detecting elevated serum
DcR3/TR6/M68 in malignant tumor patients. Int J Cancer.
105:724–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Otsuki T, Tomokuni A, Sakaguchi H, Aikoh
T, Matsuki T, Isozaki Y, Hyodoh F, Ueki H, Kusaka M, Kita S, et al:
Over-expression of the decoy receptor 3 (DcR3) gene in peripheral
blood mononuclear cells (PBMC) derived from silicosis patients.
Clin Exp Immunol. 119:323–327. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bai C, Connolly B, Metzker ML, Hilliard
CA, Liu X, Sandig V, Soderman A, Galloway SM, Liu Q, Austin CP, et
al: Overexpression of M68/DcR3 in human gastrointestinal tract
tumors independent of gene amplification and its location in a
four-gene cluster. Proc Natl Acad Sci USA. 97:1230–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ge Z, Sanders AJ, Ye L, Wang Y and Jiang
WG: Expression of death decoy receptor-3 (DcR3) in human breast
cancer and its functional effects on breast cancer cells in vitro.
J Exp Ther Oncol. 9:109–118. 2011.PubMed/NCBI
|
|
12
|
Tu HF, Liu CJ, Liu SY, Chen YP, Yu EH, Lin
SC and Chang KW: Serum decoy receptor 3 level: A predictive marker
for nodal metastasis and survival among oral cavity cancer
patients. Head Neck. 33:396–402. 2011.PubMed/NCBI
|
|
13
|
Bamias G, Gizis M, Delladetsima I, Laoudi
E, Siakavellas SI, Koutsounas I, Kaltsa G, Vlachogiannakos J,
Vafiadis-Zouboulis I, Daikos GL, et al: Elevated serum levels of
the antiapoptotic protein decoy-receptor 3 are associated with
advanced liver disease. Can J Gastroenterol Hepatol.
2016:26370102016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bamias G, Kaltsa G, Siakavellas SI,
Papaxoinis K, Zampeli E, Michopoulos S, Zouboulis-Vafiadis I and
Ladas SD: High intestinal and systemic levels of decoy receptor 3
(DcR3) and its ligand TL1A in active ulcerative colitis. Clin
Immunol. 137:242–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ao R, Du YQ, Wang Y, Chen YS and Wang BY:
MMP-2 and DcR3 expression in esophageal cancer tissue and
correlation with patient survival. Int J Clin Exp Med. 6:700–705.
2013.PubMed/NCBI
|
|
16
|
Hsu MJ, Lin WW, Tsao WC, Chang YC, Hsu TL,
Chiu AW, Chio CC and Hsieh SL: Enhanced adhesion of monocytes via
reverse signaling triggered by decoy receptor 3. Exp Cell Res.
292:241–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang CR, Hsieh SL, Ho FM and Lin WW: Decoy
receptor 3 increases monocyte adhesion to endothelial cells via
NF-kappa B-dependent up-regulation of intercellular adhesion
molecule-1, VCAM-1, and IL-8 expression. J Immunol. 174:1647–1656.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tateishi K, Miura Y, Hayashi S, Takahashi
M and Kurosaka M: DcR3 protects THP-1 macrophages from apoptosis by
increasing integrin alpha4. Biochem Biophys Res Commun.
389:593–598. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim S, Kotoula V, Hytiroglou P, Zardavas D
and Zhang L: Significance of increased expression of decoy receptor
3 in chronic liver disease. Dig Liver Dis. 41:591–598. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen G and Luo D: Expression of decoy
receptor 3 in liver tissue microarrays. Natl Med J India.
21:275–278. 2008.PubMed/NCBI
|
|
21
|
Nagar B, Overduin M, Ikura M and Rini JM:
Structural basis of calcium-induced E-cadherin rigidification and
dimerization. Nature. 380:360–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benham-Pyle BW, Pruitt BL and Nelson WJ:
Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1
and β-catenin activation to drive cell cycle entry. Science.
348:1024–1027. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishiyama N, Lee SH, Liu S, Li GY, Smith
MJ, Reichardt LF and Ikura M: Dynamic and static interactions
between p120 catenin and E-cadherin regulate the stability of
cell-cell adhesion. Cell. 141:117–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagafuchi A, Shirayoshi Y, Okazaki K,
Yasuda K and Takeichi M: Transformation of cell adhesion properties
by exogenously introduced E-cadherin cDNA. Nature. 329:341–343.
1987. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paul A, Danley M, Saha B, Tawfik O and
Paul S: PKCζ promotes breast cancer invasion by regulating
expression of E-cadherin and Zonula Occludens-1 (ZO-1) via
NFκB-p65. Sci Rep. 5:125202015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu W, Xu YC, Tao Y, He P, Li Y, Wu T, Zhu
YP, Li J, Wu JX and Dai J: DcR3 regulates the growth and metastatic
potential of SW480 colon cancer cells. Oncol Rep. 30:2741–2748.
2013.PubMed/NCBI
|
|
29
|
Mild G, Bachmann F, Boulay JL, Glatz K,
Laffer U, Lowy A, Metzger U, Reuter J, Terracciano L, Herrmann R,
et al: DCR3 locus is a predictive marker for 5-fluorouracil-based
adjuvant chemotherapy in colorectal cancer. Int J Cancer.
102:254–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Luo J, He R, Huang W, Li Z, Li P,
Dang Y, Chen G and Li S: Expression and clinicopathological
implication of DcR3 in lung cancer tissues: A tissue microarray
study with 365 cases. Onco Targets Ther. 9:4959–4968. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng XF, Miao LY, Li S and Wang YB:
Promotive effects of Dcr3 gene on the occurrence and progression of
gastric cancer and its mechanism. Hepatogastroenterology.
61:880–884. 2014.PubMed/NCBI
|
|
32
|
Hsu TL, Chang YC, Chen SJ, Liu YJ, Chiu
AW, Chio CC, Chen L and Hsieh SL: Modulation of dendritic cell
differentiation and maturation by decoy receptor 3. J Immunol.
168:4846–4853. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu SF, Liu TM, Lin YC, Sytwu HK, Juan HF,
Chen ST, Shen KL, Hsi SC and Hsieh SL: Immunomodulatory effect of
decoy receptor 3 on the differentiation and function of bone
marrow-derived dendritic cells in nonobese diabetic mice: From
regulatory mechanism to clinical implication. J Leukoc Biol.
75:293–306. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang YC, Hsu TL, Lin HH, Chio CC, Chiu
AW, Chen NJ, Lin CH and Hsieh SL: Modulation of macrophage
differentiation and activation by decoy receptor 3. J Leukoc Biol.
75:486–494. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weissinger D, Tagscherer KE,
Macher-Göppinger S, Haferkamp A, Wagener N and Roth W: The soluble
Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and
promotes migration and invasion in renal cell carcinoma. Mol
Cancer. 12:1202013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chua HL, Bhat-Nakshatri P, Clare SE,
Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin
expression and enhances epithelial to mesenchymal transition of
mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2.
Oncogene. 26:711–724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
